Palisade Bio, Inc. (PALI)
1.665
-0.08
(-4.86%)
USD |
NASDAQ |
Jan 16, 16:00
1.70
+0.04
(+2.10%)
After-Hours: 19:39
Palisade Bio Total Assets (Quarterly): 6.973M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Amicus Therapeutics, Inc. | 868.81M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.761M |
| Shareholders Equity (Quarterly) | 3.212M |
| Debt to Equity Ratio | 0.0657 |
| Current Ratio | 1.784 |
| Net Debt Paydown Yield | 0.73% |